Caladrius Biosciences Inc. (CLBS) dropped -5.28% or -0.19 to $3.41. It is approximately 20315 shares traded, which is 74.24% compare to the average total volume 27363. The market cap of CLBS is $35.37 million. The year to date change is -21.45%. The 52 week price range is from $3.05 to $11.65. Price of CLBS have changed 3.15% during last week. It have changed -10.00% over last month, -21.91% over last 3 months, -32.71% over last 6 months and -30.77% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 4.19. It is 22.87% above current price. The 200-day Moving Averages for CLBS is 4.88. It is 43.11% above current price. The 52-week High is 11.65. It is 241.64% from the current price. The 52-week Low is 3.05. It is -10.56% from current price.
There are some statistics of CLBS. It is has market cap $35.37 million. The share outstanding is 10.37 million. The average volume is 27363. The percent of top 15 Institution holding is 9.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is -37.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is -30.72%.